COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 841: Articles 8401-8410  | Next

How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics
Harris, J. D., Park, S. W., Dushoff, J., Weitz, J. S.
10.1101/2022.04.21.22274139 — Posted: 2022-04-22
SARS-CoV-2 testing of aircraft wastewater shows that mandatory tests and vaccination pass before boarding did not prevent massive importation of Omicron variant in Europe
Targa, L. L., Wurtz, N., Lacoste, A., Penant, G., Jardot, P., Annessi, A., Colson, P., LA SCOLA, B., AHERFI, S.
10.1101/2022.04.19.22274028 — Posted: 2022-04-22
Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
Lei, J., Clements, M., Elfström, M., Lundgren, K. C., Dillner, J.
10.1101/2022.04.22.22274163 — Posted: 2022-04-22
A within-host model of SARS-CoV-2 infection
Carruthers, J., Xu, J., Finnie, T. J. R., Hall, I.
10.1101/2022.04.22.22274137 — Posted: 2022-04-22
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
Orangi, S., Ojal, J., Brand, S. P. C., Orlendo, C., Kairu, A., Aziza, R., Ogero, M., Agweyu, A., Warimwe, G. M., Uyoga, S., Otieno, E., Ochola-Oyier, L. I., Agoti, C. N., Kasera, K., Amoth, P., Mwangangi, M., Aman, R., Ng'ang'a, W., Adetifa, I. M. O., Scott, J. A. G., Bejon, P., Keeling, M. J., Flasche, S., Nokes, D. J., Barasa, E.
10.1101/2022.04.21.22274150 — Posted: 2022-04-22
Prosocial motivation for vaccination
Reddinger, J. L., Charness, G., Levine, D.
10.1101/2022.04.21.22274110 — Posted: 2022-04-22
SARS-CoV-2 spike variants differ in their allosteric response to linoleic acid
Oliveira, A. S. F., Shoemark, D. F., Davidson, A. D., Berger, I., Schaffitzel, C., Mulholland, A. J.
10.1101/2022.04.21.489022 — Posted: 2022-04-22
The Free Fatty Acid-Binding Pocket is a Conserved Hallmark in Pathogenic β-Coronavirus Spike Proteins from SARS-CoV to Omicron
Toelzer, C., Gupta, K., Yadav, S. K. N., Hodgson, L., Kavanagh Williamson, M., Buzas, D., Borucu, U., Powers, K., Stenner, R., Vasileiou, K., Garzoni, F., Fitzgerald, D., Payre, C., Lambeau, G., Davidson, A. D., Verkade, P., Frank, M., Berger, I., Schaffitzel, C.
10.1101/2022.04.22.489083 — Posted: 2022-04-22
Intrinsic furin-mediated cleavability of the spike S1/S2 site from SARS-CoV-2 variant B.1.529 (Omicron)
Lubinski, B., Jaimes, J. A., Whittaker, G.
10.1101/2022.04.20.488969 — Posted: 2022-04-22
An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP Immunization
Hsu, F.-F., Liang, K.-H., Kumari, M., Chen, W. Y., Lin, H. T., Cheng, C. M., Tao, M.-H., Wu, H.-C.
10.1101/2022.04.20.488878 — Posted: 2022-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).